GlobeNewswire 04/12/2025 Denali Therapeutics and Royalty Pharma Announce $275 Million Royalty Funding Agreement
GlobeNewswire 02/12/2025 Conflicting Guidance and Rapid Innovation Leave Physicians Seeking Clarity in Relapsed/Refractory Mu...
GlobeNewswire 02/12/2025 Health-ISAC® Announces results of 2026 Board of Directors Election
GlobeNewswire 02/12/2025 ADARx Pharmaceuticals Appoints Mary Tagliaferri, M.D., to its Board of Directors
GlobeNewswire 01/12/2025 Amneal Announces U.S. FDA Approval of Cyclosporine Ophthalmic Emulsion 0.05%
GlobeNewswire 26/11/2025 Royalty Pharma to Present at Upcoming Investor Conferences
GlobeNewswire 24/11/2025 Clearside Biomedical to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
GlobeNewswire 19/11/2025 European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lym...
GlobeNewswire 18/11/2025 Genmab Announces EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide Approved...
GlobeNewswire 17/11/2025 James M. O’Brien Appointed Chief Financial Officer at Mesoblast
GlobeNewswire 13/11/2025 Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2025 Financial Results
GlobeNewswire 13/11/2025 25 Companies Earn Spot on the 2025 Fortune World’s Best Workplaces List
GlobeNewswire 12/11/2025 Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update
GlobeNewswire 12/11/2025 Chiesi Group Enters into an Exclusive License Agreement with Aliada Therapeutics, a Wholly Owned Sub...
GlobeNewswire 12/11/2025 Chiesi Group Enters into an Exclusive License Agreement with Aliada Therapeutics, a Wholly Owned Sub...
GlobeNewswire 12/11/2025 LB Pharmaceuticals Appoints Kaya Pai Panandiker as Chief Commercial Officer
GlobeNewswire 12/11/2025 Psyence BioMed Establishes Ibogaine Operations in Africa Through Strategic Investment in PsyLabs
GlobeNewswire 07/11/2025 ADARx Pharmaceuticals Announces Positive Interim Phase 1 Clinical Data for its Novel siRNA Targeting...
GlobeNewswire 07/11/2025 Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC an...
GlobeNewswire 07/11/2025 Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immu...
GlobeNewswire 07/11/2025 Dr. Adrian Bot joins Immuthera to support the company with his unique experience in commercializatio...
GlobeNewswire 06/11/2025 Genmab Announces Financial Results for the Nine Months of 2025
GlobeNewswire 06/11/2025 Climb Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates
GlobeNewswire 05/11/2025 Royalty Pharma Reports Third Quarter 2025 Results
GlobeNewswire 04/11/2025 Royalty Pharma Acquires Royalty Interest in Alnylam’s AMVUTTRA for $310 Million from Blackstone Life...